Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Faten Koraïchi
Observed names:
Faten Koraichi,
Faten Koraichi Auriol,
Koraïchi, Faten
Institution:
Menarini Group (Italy)
Observed institutions:
Centre National de la Recherche Scientifique,
Université Toulouse III - Paul Sabatier,
Inserm,
Centre de Recherches en Cancérologie de Toulouse,
Menarini Group (Italy),
Institut Claudius Regaud,
Hôpital Purpan,
Université de Toulouse
show all 8
ORCID:
0000-0002-8636-6411
Observed ORCID:
0000-0002-8636-6411
OpenAlex ID:
A5020618792
A New Protein-Protein Interaction Sensor Based on Tripartite Split-GFP Association
2013
·
Stéphanie Cabantous
, Hau B. Nguyen
, et al.
·
Scientific Reports
·
277
PDF
High-content tripartite split-GFP cell-based assays to screen for modulators of small GTPase activation
2017
·
Faten Koraïchi
, Rémi Gence
, et al.
·
Journal of Cell Science
·
29
Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram‐negative bacterial infections
2024
·
Chiara Fornari
, Antonio Arrieta
, et al.
·
British Journal of Clinical Pharmacology
·
9
PDF
Visualizing the subcellular localization of RHOB-GTP and GTPase-Effector complexes using a split-GFP/nanobody labelling assay
2023
·
Sebastian Castillo
, Rémi Gence
, et al.
·
European Journal of Cell Biology
·
7
Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling
2022
·
Laura Keller
, Claudine Tardy
, et al.
·
Frontiers in Immunology
·
5
Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial
2025
·
Giovanni Martinelli
, Scott R. Solomon
, et al.
·
Blood Neoplasia
·
3
Elacestrant in Combination with Everolimus for Estrogen Receptor–Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE
2026
·
Hope S. Rugo
, Sara M. Tolaney
, et al.
·
Clinical Cancer Research
·
2
Cltr-07 Electra: an Open-label, Multicenter, Phase 1b/2 Study of Elacestrant in Combination With Abemaciclib in Patients With Brain Metastases From Er+/her2– Breast Cancer
2026
·
Nancy U Lin
, Milana Bergamino Sirven
, et al.
·
Neuro-Oncology Advances
Elacestrant in combination with capivasertib in patients with ER+/HER2− advanced breast cancer: Update from ELEVATE, a phase 1b/2, open-label, umbrella study.
2026
·
Wassim McHayleh
, Sara M. Tolaney
, et al.
·
Journal of Clinical Oncology
Split-GFP based cellular assays to screen modulators of small GTPase activation
2019
·
Koraïchi, Faten
, Gence, Rémi
, et al.
·
HAL
Développement d'un biosenseur pour l'étude de l'activation de la GTPase RhoB par complémentation split-GFP tripartite
2016
·
Faten Koraïchi
Etude de l'activation de la GTPase RhoB par complémentation split-GFP tripartite
2016
·
Faten Koraïchi
·
theses.fr (ABES)
Monitoring protein-protein interactions using tripartite split-GFP complementation assays
2015
·
Stéphanie Cabantous
, Hau B. Nguyen
, et al.
Influence des immunosuppresseurs co-administrés au mycophénolate mofétil lors du dosage de l’acide mycophénolique par technique immuno-enzymatique
2011
·
Peggy Gandia
, Faten Koraïchi
, et al.
·
Annales de Toxicologie Analytique
PDF
Évaluation de l’automate Architect®ci4100TMpour une utilisation en routine dans un laboratoire de pharmaco-toxicologie
2010
·
Peggy Gandia
, François Guder
, et al.
·
Annales de Toxicologie Analytique
PDF
Show more works
View as search
Works count:
15
Citation count:
332
H-index:
5
I10-index:
2
Year
Topic
Type
